Colipral(R) capsules

Colipral(R) capsules
Product Description

Colipral(R) capsules Colipral(R) is an innovative probiotic supplement developed with Escherichia coli 5C (ECP24(R)), a thoroughly characterized and genomically safe strain of human origin. Each enteric-coated capsule delivers a high concentration of at least 1×10⁹ CFU, ensuring the microorganism reaches the intestine intact. E. coli 5C has been specifically selected for its strong adhesion capacity to colon cells (84%), its anti-inflammatory properties, and its competitive activity against pathogenic intestinal E. coli. Scientific evidence supports its clinical potential across several therapeutic areas: in recurrent prostatitis and cystitis prevention, Colipral(R) competes with pathogens at receptor level; in ulcerative colitis in remission, it modulates inflammation by stimulating IL-10 release, enhancing acetate and butyrate production through cross-feeding; and after colonoscopy, it helps restore intestinal balance by reducing oxygen tension and supporting butyrate-producing bacteria. Genomic studies confirm its safety profile, with no evidence of translocation or bladder colonization, and an antibiotic resistance profile compliant with EFSA cut-off values. Naturally gluten- and lactose-free, Colipral(R) represents a new generation of precision probiotics, combining safety, functionality, and efficacy for targeted intestinal and systemic benefits

PHARMEXTRACTA S.P.A.

  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Wholesale/Retail

PHARMEXTRACTA S.P.A.

  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Wholesale/Retail

More Products from PHARMEXTRACTA S.P.A. (21)

  • Gabapral® Stick packs

    Product Gabapral® Stick packs

    Gabapral® is a probiotic food supplement specifically developed for children with Irritable Bowel Syndrome (IBS) and Recurrent Abdominal Pain (RAP), helping improve abdominal pain, bowel habits and overall IBS-related symptoms.

    It contains Bifidobacterium adolescentis PRL2019, a highly charact...
  • Zantogin® Gel

    Product Zantogin® Gel

    Zantogin® Gel is a vaginal medical device specifically designed to protect, moisturize and promote the restoration of the vaginal mucosa, particularly in cases of vaginal atrophy and vulvar irritation.

    Its formulation combines hyaluronic acid and Centella asiatica with Zanthalene®, Polycarboph...
  • Kramegin®

    Product Kramegin®

    Kramegin® is a vaginal medical device designed to support the restoration of the vaginal environment in cases of bacterial and fungal imbalance.

    Its formulation combines boric acid and lactic acid with Krameria triandra, providing targeted local action and helping maintain physiological vagina...
  • Hepa G®

    Product Hepa G®

    Hepa G® is a food supplement specifically formulated to support liver health through antioxidant and hepatoprotective activity.

    It combines Siliphos® Silybin Phytosome®, a highly bioavailable silybin-phosphatidylcholine complex, with L-cysteine, L-methionine and L-serine, three amino acids inv...
  • Crispact® Stick Packs

    Product Crispact® Stick Packs

    Crispact® is a probiotic food supplement specifically developed to support a healthy vaginal microbiota and promote the dominance of Lactobacillus crispatus, one of the most protective Lactobacillus species in the vaginal environment.

    It contains Lactobacillus crispatus M247, a highly characte...
  • Berberol®

    Product Berberol®

    Berberol® is a food supplement designed to support lipid and glucose metabolism in subjects with dyslipidemia, diabetes or metabolic syndrome.

    Its patented formulation combines Berberine with Silymarin from milk thistle, which acts as a bioenhancer and improves Berberine bioavailability and ef...
  • Sophy(R) tablets

    Product Sophy(R) tablets

    Sophy(R) tablets Sophy(R) is a clinically proven food supplement designed for women with Polycystic Ovary Syndrome (PCOS). It harnesses the power of Berberine Phytosome(R), a berberine-phospholipid complex that enhances absorption and delivers 10 times higher bioavailability compared to standard berberine....
  • Bactorinol(R)

    Product Bactorinol(R)

    Bactorinol(R) nasal drops contains Winterized Lentisk Oil a novel ingredient with antibacterial activity, able to disrupt bacterial biofilms to eradicate biofilm-related infections of the upper respiratory tract. To be used alone or as add-on therapy to antibiotic therapies.
  • Berberol(R)

    Product Berberol(R)

    Berberol(R) is the first food supplement containing berberine that overcame the issue of the very poor bioavailability of this botanical ingredient thanks to its patented formulation featuring Silymarin. The effectiveness of this supplement in blood sugar and blood fat control has been confirmed by sever...
  • Brevicillin® Drops

    Product Brevicillin® Drops

    Brevicillin® Drops is a probiotic food supplement designed to support the balance of the gut microbiota during treatment with Amoxicillin or Amoxicillin/Clavulanic Acid, with an easy-to-administer formulation suitable for children, including infants.

    It contains Bifidobacterium breve PRL2020, ...
  • Crispact® Capsules

    Product Crispact® Capsules

    Crispact® is a probiotic food supplement specifically developed to support a healthy vaginal microbiota and promote the dominance of Lactobacillus crispatus, one of the most protective Lactobacillus species in the vaginal environment.

    It contains Lactobacillus crispatus M247, a highly characte...
  • Bactorinol® Nasal Spray

    Product Bactorinol® Nasal Spray

    Bactorinol® is a nasal medical device designed to support the management of rhinosinusitis, rhinitis and nasal congestion, helping fluidify thick secretions, clear the nasal passages and facilitate breathing.

    It contains Winterized Lentisk Oil obtained from Pistacia lentiscus berries, characte...

PHARMEXTRACTA S.P.A. resources (3)

  • Brochure PharmExtracta Product Portfolio 2026

    Discover PharmExtracta’s 2026 product portfolio, featuring clinically supported and innovative solutions across Precision Bacterial Care, botanical products, precision prebiotics and biomolecular supplements. The brochure provides an overview of our products, targeted health areas, biopharmaceutical compositions, formulation technologies and directions for use, highlighting PharmExtracta’s science-driven approach to product development.
  • Brochure PharmExtracta – Top Therapeutic Areas & Medical Devices 2026

    Explore PharmExtracta’s key therapeutic areas and discover our portfolio of probiotics, botanicals, micronutrients and medical devices. This concise overview maps our product solutions across major health areas and provides dedicated insights into selected medical devices for ENT and women’s health applications.
  • Datasheet PharmExtracta – Company Profile 2026

    An overview of PharmExtracta, its scientific approach, business model, market presence and product portfolio, highlighting the company’s expertise in developing and bringing evidence-based healthcare solutions to market.